Form 4 for BCDA BioCardia, Inc.
Accepted 2022-04-18 00:00:00 ET · period of report 2022-04-14 · accession 0001437749-22-009164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-18 | 2022-04-14 | BCDA | GILLIS EDWARD M | SVP, Devices | A - Grant | $0.00 | +30.2K | 36.2K | +496% | $0 |
| D | 2022-04-18 | 2022-04-14 | BCDA | GILLIS EDWARD M | SVP, Devices | A - Grant | $0.00 | +38.0K | 38.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-14 | A | A | 30,155 | $0.00 | 36,237 | D | — | — | (F1) The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022. |
| 2 | Derivative | Stock Option (right to buy) | 2022-04-14 | A | A | 38,000 | $0.00 | 38,000 | D | $1.49 · — to 2032-04-14 | 38,000 Common Stock | (F2) The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. |